Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Correction for Nonspecific Binding to Various Components of Ultrafiltration Apparatus and Impact on Estimating In Vivo Rat Clearance for a Congeneric Series of 5-Ethyl, 5-n-Alkyl Barbituric Acids

Peter Ballard and Malcolm Rowland
Drug Metabolism and Disposition December 2011, 39 (12) 2165-2168; DOI: https://doi.org/10.1124/dmd.111.040683
Peter Ballard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malcolm Rowland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 39 no. 12 2165-2168
DOI 
https://doi.org/10.1124/dmd.111.040683
PubMed 
21880830

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 10, 2011
  • Accepted August 31, 2011
  • Published online November 21, 2011.

Article Versions

  • Earlier version (August 31, 2011 - 07:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Peter Ballard and
  2. Malcolm Rowland
  1. AstraZeneca Pharmaceuticals, Alderley Park, Cheshire, United Kingdom (P.B.); and School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, United Kingdom (M.R.)
  1. Address correspondence to:
    Peter Ballard, AstraZeneca, Mereside, Alderley Park, Cheshire, SK10 4TG, UK. E-mail: peter.ballard{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2011 to January 2021

AbstractFullPdf
Aug 201162010
Sep 2011301072
Oct 201167024
Nov 2011492969
Dec 20116931591
Jan 2012142838
Feb 2012143928
Mar 2012120629
Apr 201275419
May 201268313
Jun 201248231
Jul 20125128
Aug 201242417
Sep 201278315
Oct 201257216
Nov 201257116
Dec 201246925
Jan 2013522529
Feb 2013351517
Mar 2013261122
Apr 2013292618
May 2013301628
Jun 2013999
Jul 20131157
Aug 201324169
Sep 201317158
Oct 20132786
Nov 2013181510
Dec 20132259
Jan 2014191725
Feb 2014271027
Mar 2014161816
Apr 2014123134
May 2014221529
Jun 2014141413
Jul 201417195
Aug 201413109
Sep 201415178
Oct 20141677
Nov 201418168
Dec 20141558
Jan 2015161410
Feb 20151266
Mar 2015192113
Apr 2015242111
May 2015211812
Jun 2015202314
Jul 2015223016
Aug 2015152514
Sep 2015162111
Oct 2015121912
Nov 201512167
Dec 20156107
Jan 2016151314
Feb 20169157
Mar 2016162412
Apr 201613193
May 2016161915
Jun 201626910
Jul 201681011
Aug 2016191611
Sep 20169114
Oct 201672122
Nov 20161105
Dec 20160144
Jan 20171193
Feb 201702611
Mar 201713111
Apr 20170128
May 20170146
Jun 2017081
Jul 2017251
Aug 20171127
Sep 201703214
Oct 201701718
Nov 201732013
Dec 20170183
Jan 20180146
Feb 201801714
Mar 20180288
Apr 201863612
May 20181227
Jun 201802512
Jul 201811513
Aug 20180209
Sep 20180159
Oct 20180316
Nov 20180177
Dec 20181255
Jan 20192914
Feb 201927112
Mar 201919310
Apr 201940010
May 20192068
Jun 2019928
Jul 20192317
Aug 20192923
Sep 20192275
Oct 20192729
Nov 201926411
Dec 201929212
Jan 20202009
Feb 20201347
Mar 202019211
Apr 202014010
May 2020704
Jun 20201926
Jul 2020903
Aug 2020804
Sep 20201515
Oct 20201403
Nov 202028310
Dec 202023310
Jan 20212516

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (12)
Drug Metabolism and Disposition
Vol. 39, Issue 12
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction for Nonspecific Binding to Various Components of Ultrafiltration Apparatus and Impact on Estimating In Vivo Rat Clearance for a Congeneric Series of 5-Ethyl, 5-n-Alkyl Barbituric Acids
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

ESTIMATING NONSPECIFIC BINDING BY ULTRAFILTRATION

Peter Ballard and Malcolm Rowland
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2165-2168; DOI: https://doi.org/10.1124/dmd.111.040683

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationShort Communication

ESTIMATING NONSPECIFIC BINDING BY ULTRAFILTRATION

Peter Ballard and Malcolm Rowland
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2165-2168; DOI: https://doi.org/10.1124/dmd.111.040683
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Conclusion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more SHORT COMMUNICATIONS

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics